The NIHR Community Healthcare MIC are hosting two important workshops, which will take place in February and March. Members must complete a submission of interest form – which will be accessible below – to attend the workshops.
The full blurbs are available here:
Diagnostics for Early Cancer Detection
Early detection of cancers is an NHS and CRUK priority and an area of considerable innovation by researchers and developers of diagnostics. Dr Brian Nicholson is a GP and Cancer Detection Lead for the Nuffield Department of Primary Care and a MIC key researcher. He is leading a number of research programmes in collaboration with the Oxford CRUK Cancer Centre, which are evaluating novel methods for cancer detection. Our workshop will provide the opportunity for developers of early cancer detection diagnostics to have focussed discussions with researchers from the NIHR Community Healthcare MIC and its strategic partners who have expertise in early cancer detection.
Four 40 minute appointments will be available for companies to meet with the panel. Companies will have the opportunity to make a 10 minute presentation of their diagnostic followed by a discussion regarding the technology, the next steps required in evidence generation, and the potential for collaboration. The aim will be to take promising technologies forward beyond the meeting into collaborative funding applications which will allow the required evidence to be generated.
We invite interested developers of diagnostics to complete an expression of interest form to register their interest to attend the workshop; we will be particularly interested to hear from developers of multi-cancer diagnostics for which samples could be collected in primary care or other community healthcare settings. Successful applicants will be offered an appointment to join our workshop, which will take place in February or March online.
Diagnostics for Acute Chronic Breathlessness
Optimising management of respiratory conditions is a key priority in the NHS Long Term Plan. “Treatable traits” approaches based on underlying disease mechanisms rather than diagnostic labels are increasingly being advocated. Dr Kay Wang is a GP and Senior Clinical Research Fellow at the Nuffield Department of Primary Care. She is co-leading a major NIHR-funded programme of research on biomarker-guided asthma management in primary care.
Our workshop will provide the opportunity for developers of diagnostics aimed at patients with acute or chronic breathlessness to have focussed discussions with researchers from the NIHR Community Healthcare MIC and its strategic partners who have expertise in respiratory diagnostics.
Three 40 minute appointments will be available for companies to meet with the panel. Companies will have the opportunity to make a 10 minute presentation of their diagnostic followed by a discussion regarding the technology, the next steps required in evidence generation, and the potential for collaboration. The aim will be to take promising technologies forward beyond the meeting into collaborative funding applications which will allow the required evidence to be generated.
We invite interested developers of diagnostics to complete an expression of interest form to register their interest to attend the workshop; we will be particularly interested to hear from developers of diagnostics which can be implemented in primary care or other community healthcare settings. Successful applicants will be offered an appointment to join our workshop, which will take place in March online.
